Physician profile
Christopher Lutman
NPI 1255321568
$1,387.72
in general payments reported to CMS, 2019-2025
17 companies · $550 in 2025
The $550 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.96 · 2020: $99.60 · 2021: $57.27 · 2022: $103 · 2023: $210 · 2024: $270 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $221.22 | 2022-2025 | Jemperli |
| Pfizer INC. | $165.46 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $143.44 | 2019-2025 | Imfinzi, Calquence |
| Janssen Biotech, INC. | $142.78 | 2023-2025 | Darzalex, Talvey, Erleada |
| Seagen INC. | $120.91 | 2023 | Tivdak |
| Hologic Sales and Service, LLC | $114.30 | 2024-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Ethicon US, LLC | $89.66 | 2019-2025 | Harmonic, Enseal |
| Intuitive Surgical, INC. | $84.70 | 2024-2025 | |
| Abbvie INC. | $58.61 | 2025 | |
| Merck Sharp & Dohme LLC | $52.48 | 2019-2021 | |
| Eisai INC. | $49.04 | 2023-2024 | |
| Clovis Oncology, INC. | $44.08 | 2020 | |
| Baxter Healthcare | $25.47 | 2020 | |
| Deciphera Pharmaceuticals INC. | $22.51 | 2025 | Tgct, Qinlock |
| Array Biopharma INC | $20.79 | 2025 | Braftovi, Mektovi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $19.08 | 2024 | Ayvakit |
| Lilly USA, LLC | $13.19 | 2023 | Jaypirca, Verzenio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lutman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.